23 May 2013
Keywords: pfizer, germany, sees, recovery, facing, serious, sales
Article | 12 September 2005
Facing a serious sales downturn of its cholesterol-lowering drug Sortis (Lipitor; atorvastatin) on the German drug market in 2005, Pfizer has
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 September 2005
22 May 2013
© 2013 thepharmaletter.com